Hypoadiponectinemia as a marker of adipocyte dysfunction -- Part I: the biology of adiponectin.

Naftali Stern*, Etty Osher, Yona Greenman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Adiponectin is the most abundantly secreted adipocyte-derived peptide hormone, possessing an array of antidiabetogenic and cardiovascular protective effects. Acting through 2 distinct membrane receptors, adiponectin receptors 1 and 2 (which utilize 5'-adenosine monophosphate-activated protein kinase phosphorylation, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha as key cell signaling elements), adiponectin increases hepatic and skeletal muscle sensitivity to insulin, enhances fatty acid oxidation, suppresses monocyte-endothelial interaction, supports endothelial cell growth, lowers blood pressure, and moderates adipose tissue growth. The secretion of adiponectin can be suppressed by adipose factors, which are turned on once fat cell mass increases, such as cytokines, adipose renin-angiotensin system, and increased oxidative stress. Inhibition of adiponectin secretion results in the loss of an array of mechanisms, which under normal conditions of fat cell homeostasis provide protection from insulin resistance, diabetes, and atherosclerosis.

Original languageEnglish
Pages (from-to)174-182
Number of pages9
JournalJournal of the CardioMetabolic Syndrome
Issue number3
StatePublished - 2007


Dive into the research topics of 'Hypoadiponectinemia as a marker of adipocyte dysfunction -- Part I: the biology of adiponectin.'. Together they form a unique fingerprint.

Cite this